Schizophrenia
|
0.410 |
Biomarker
|
disease |
BEFREE |
By applying ICSNPathway analysis to schizophrenia GWAS data, we identified candidate SNPs, genes like KCNQ2 and APOL2 and pathways involving the estrogen biosynthetic process may contribute to schizophrenia susceptibility.
|
23644028 |
2013 |
Schizophrenia
|
0.410 |
Biomarker
|
disease |
CTD_human |
|
|
|
Schizophrenia
|
0.410 |
Biomarker
|
disease |
HPO |
|
|
|
Cannabis Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Cannabis Dependence
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Cocaine Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Hashish Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Marijuana Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Phencyclidine Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Cannabis-Related Disorder
|
0.300 |
Biomarker
|
group |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Cocaine-Related Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Phencyclidine-Related Disorders
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Cocaine Dependence
|
0.300 |
Biomarker
|
disease |
CTD_human |
Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse.
|
17205118 |
2006 |
Delusions
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hallucinations
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Negativism
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Social and occupational deterioration
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Alcohol Use Disorder
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The genome-wide meta-analysis of EAA in AUD revealed a significant single nucleotide polymorphism (SNP), rs916264 (p = 5.43 × 10<sup>-8</sup>), in apolipoprotein L2 (APOL2) at the genome-wide level.
|
31466081 |
2020 |
Irritable Bowel Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Regions of the salience network, including the mid cingulate cortex, and mid and superior temporal gyrus were positively correlated with several pro-inflammatory genes (interleukin 6, APOL2) in IBS, but negatively correlated with several anti-inflammatory genes (KRT8, APOA4) in HCs.
|
28191693 |
2017 |
Influenza A
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
ApoL2 mRNA expression was also elevated in normal human lung fibroblasts and smooth muscle cells stimulated with IFN-γ, in lung tissues from an IFN-γ-predominant influenza A virus-infected mouse lung injury model, and in cancer lung tissues from human patients.
|
20665705 |
2011 |
Lichen planus follicularis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Specific genes, such as MMP11, TNFSF13B, and APOL2, were identified with significantly differential expression in association with LPP versus PPB.
|
19932600 |
2010 |
Pleuropulmonary blastoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Specific genes, such as MMP11, TNFSF13B, and APOL2, were identified with significantly differential expression in association with LPP versus PPB.
|
19932600 |
2010 |